{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL7sxOIKDA","lastupdate":"2023-02-09T00:00:00.000Z","update_date":"2023-02-09T00:00:00.000Z","lastModified":"Sep 7, 2024","active":1,"confidence_score":92,"confidence_score_reason":"markets, not claimed","urlname":"apifix","minimal_profile":null,"status":"Acquired","fullstatus":"Acquired by Orthopediatrics on Apr, 2020","acquired":1,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$Faxzl9aC8tgpMBgK4CxF2hGkEu1caA185Xaq6Ja84UBkd99jZR6ZHF","name":"ApiFix","oneliner":"Minimally Invasive Scoliosis Treatment","registrar":"514584747","website":"https://apifix.com","careerspage":"","founded_month":3,"founded_year":2011,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/ApiFix","youtube":"https://www.youtube.com/channel/UCvPLPheAOrplckoGviotA7w","facebook":"https://www.facebook.com/ApiFix","linkedin":"https://www.linkedin.com/company/5069168","instagram":""},"social":["https://www.facebook.com/ApiFix","https://www.linkedin.com/company/5069168","https://twitter.com/ApiFix","https://www.youtube.com/channel/UCvPLPheAOrplckoGviotA7w"],"flattenedsociallinks":"https://www.facebook.com/ApiFix|https://www.linkedin.com/company/5069168|https://twitter.com/ApiFix|https://www.youtube.com/channel/UCvPLPheAOrplckoGviotA7w","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":11,"patent":1,"raised":8000000,"stage":"Acquired","public_stage":"Acquired","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Api Fix","Api-Fix"],"about":"ApiFix provides a minimally invasive scoliosis correction system for treating patients with adolescent idiopathic scoliosis whoare classified as Lenke type 1 or type 5 with a Cobb angle of 40 to 60 degrees.\r\n\r\nUnlike traditional scoliosis correction procedures,which tryto fix the deformity in one aggressive and complex operation, the ApiFix system is based on a minimal surgical intervention and a correction process that spans several months and incorporates the aid of physical therapy.\r\n\r\nThe ApiFix Internal Brace System is attached to the spine viatwo pedicle screws that are inserted on both sides of the apex of the major curve. The incision is approximately 10 cm long, and the procedure takes about one hour. The expandable rod located between the two screws incorporates a miniature ratchet mechanism that captures incremental deformity corrections while the patient performs side-bending exercises to the corrective direction at home for six months after the operation.\r\n\r\nIn August 2019, the company received approval from the US Food and Drug Administration via a humanitarian device exemption to market the minimally invasive deformity correction system for the treatment of progressive adolescent idiopathic scoliosis.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+972722607056","country":null,"address":{"israeli":[{"id":"c463031b-4c2b-4e0d-8135-f7d8f29fd7f1","city":"Yokne'am Illit","type":null,"address":"HaCarmel St 1, Yokne'am Illit, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"V6F6pxBrjagcSqXd7iXSUEXE1FwImp5AUTG2E607JMyGGfR2N6ad00","city":"Warsaw","address":"2850 Frontier Dr, Warsaw, IN 46582, USA","country":"United States","placeid":null}]},"headquarter_address":null,"district":"North District","news":[{"id":"x15lRIJ7eZ9KPe481kcZeQWYQfbLnkabqFx2phIj8DJgXCb6hiWNM7","date":"Apr 12, 2022","link":"https://finance.yahoo.com/news/orthopediatrics-spotlights-award-winning-apifix-120000844.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"medical technology","company":"OrthoPediatrics Corp.","layoffs":null,"summary":"OrthoPediatrics Corp.s ApiFix System has been named the Gold Winner of the 2022 Medical Design Excellence Awards. The company showcased its award-winning technology at the 2022 International Meeting on Advanced Spine Techniques (IMAST). OrthoPediatrics also highlighted other products, including the RESPONSE Scoliosis System, FIREFLY Pedicle Screw Navigation Guides, and 7-D Image Guided Surgery technology. The ApiFix System offers a non-fusion alternative to adolescent idiopathic scoliosis surgery and has the potential to disrupt the continuum of care for scoliosis treatment. OrthoPediatrics acquired ApiFix Ltd. in April 2020. The ApiFix system has FDA and CE Mark approvals and is available in multiple countries.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["ApiFix System","Medical Design Excellence Awards","IMAST meeting","RESPONSE Scoliosis System","ApiFix procedure"],"date_of_event":"April 12, 2022","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"zAvQiIlNeiHjr1nIbI7EROo8Pvl4SW4BxA2gmr0Va2BzSNfqmFf9n9","news_summary":"OrthoPediatrics Spotlights Award-Winning ApiFix® Technology at IMAST","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"e1e2680a-098f-456b-8f01-8819be9765c6","date":"Apr 2, 2020","link":"https://en.globes.co.il/en/article-orthopediatrics-buys-israeli-co-apifix-for-40m-1001324347","source":"en.globes.co.il","visible":1,"analysis":{"tags":"acquisition","company":"OrthoPediatrics Corp.","layoffs":null,"summary":"OrthoPediatrics Corp. has acquired ApiFix, an Israeli scoliosis treatment device company. The acquisition will allow OrthoPediatrics to fill a major treatment gap and potentially avoid fusion surgery. ApiFix has developed a minimally invasive deformity correction system for non-fusion treatment of progressive adolescent idiopathic scoliosis. The MID-C system, approved by the FDA, provides permanent curve correction while retaining spine flexibility. OrthoPediatrics will pay 934,768 shares of common stock and $2 million in cash, with additional milestone payments and earn-outs over four years. The total additional payments could be at least $30 million. The acquisition is expected to contribute to the growth of non-fusion procedures. The event occurred on April 2, 2020.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["OrthoPediatrics Corp.","ApiFix","scoliosis treatment","non-fusion treatment","FDA approval"],"date_of_event":"2020-04-02","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition"],"acquisition_amount":null,"structuredIssuesShow":"#Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"hWihgoqGDMbV3jkpGF6nc7gLuhZtBcFTihRv9R7NG9iNRx1tB3VLsE","news_summary":"OrthoPediatrics buys Israeli co ApiFix for at least $67m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"8d4f153e-956c-42a9-bd13-198fd1975f4d","date":"Dec 1, 2019","link":"https://medtechinnovator.org/fda-approves-apifix-mid-c-system-for-progressive-ais/","source":"medtechinnovator.org","visible":1,"analysis":{"tags":"medical devices, scoliosis","company":"ApiFix","layoffs":null,"summary":"Israeli medical devices manufacturer ApiFix has received FDA approval for its minimally invasive deformity correction system for the treatment of progressive adolescent idiopathic scoliosis. The MID-C system, which is a motion-preserving alternative to spinal fusion, allows for permanent curve correction while retaining spine flexibility. The FDA approval is a significant achievement for ApiFix and provides an FDA-approved alternative treatment option for patients and their families. The MID-C system works as an internal brace with a self-adjusting rod mechanism and enables additional post-operative correction over time.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["FDA approval","MID-C system","adolescent idiopathic scoliosis","less invasive treatment","motion-preserving alternative"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"SJdNI0OyGqZZLRdpulR8xqUDoggemm8wrhBTD7SOadeOC5cKkHJGD8","news_summary":"FDA approves ApiFix MID-C system for progressive AIS - MedTech Innovator","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"70e9cd28-8718-40ae-a3d5-947654f7750d","date":"Aug 27, 2019","link":"https://www.businesswire.com/news/home/20190827005604/en/ApiFix-Receives-FDA-Approval-Commercialize-MID-C-System","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"5L3yMPE7h5JknjSxxEYqNwznu7KxVEu43lxojlf89gM0GvYVnzAoz7","news_summary":"ApiFix Receives FDA Approval to Commercialize MID-C System for Motion-Preserving Deformity Treatment of Progressive Idiopathic Scoliosis in Adolescents","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"40e9b3f9-6c43-447d-94b0-beadddb83c89","date":"Apr 23, 2019","link":"https://www.businesswire.com/news/home/20190423005778/en/ApiFix-Completes-Financing-Prepare-Commercial-Efforts-United","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"svFcD9bTmfu3htGfS6OUtWJ49uoj8MyoWbMgIxGMo5HtOA3B8BkeDM","news_summary":"ApiFix Completes Financing to Prepare for Commercial Efforts in the United States","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"928daa25-1285-4b2b-895e-731da8b28c60","date":"Oct 2, 2018","link":"https://www.marketwatch.com/press-release/apifix-surpasses-250-scoliosis-patients-treated-and-six-year-follow-up-of-earliest-cases-2018-10-02","source":"www.marketwatch.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"a4bklAhFhvQFk0435Jms0saB9dmXQvhibnugJSgTNo9i0CtVeQwLGF","news_summary":"https://www.marketwatch.com/press-release/apifix-surpasses-250-scoliosis-patients-treated-and-six-year-follow-up-of-earliest-cases-2018-10-02","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"4456dada-5998-4d0f-9ac0-9fb2e7043bf6","date":"Jul 30, 2018","link":"https://www.beckersspine.com/spine/item/41991-canadian-surgeon-performs-1st-apifix-scoliosis-surgery-in-north-america-4-key-insights.html","source":"www.beckersspine.com","visible":1,"analysis":{"tags":"scoliosis surgery","company":"ApiFix","layoffs":null,"summary":"Dr. Ron El-Hawary performed adolescent idiopathic scoliosis surgery using the ApiFix procedure at the IWK Health Centre in Halifax, Canada. The IWK Health Centre is the only facility in North America to offer the procedure. The ApiFix System, which uses one rod with flexible joints, provides an alternative to spinal fusion surgeries and may allow for more postsurgical spinal mobility. Dr. El-Hawary is the chief of orthopedics at the IWK Health Centre and an associate professor at Dalhousie University Faculty of Medicine in Halifax.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["ApiFix procedure","spinal fusion","surgical treatment","orthopedics","scoliosis"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Kz8wx0WMSbUm8XQWdFnKbdS63RYrDmFg8aa6C4IjrJVd258n7KCIQw","news_summary":"Canadian surgeon performs 1st ApiFix scoliosis surgery in North America: 4 key insights","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"c9f65262-3316-4a5e-874b-96684861a1ed","date":"Jul 25, 2018","link":"https://www.cbc.ca/news/canada/nova-scotia/apifix-scoliosis-iwk-hospital-spine-1.4761640","source":"www.cbc.ca","visible":1,"analysis":{"tags":["medical","surgery","spinal surgery","scoliosis"],"company":"IWK Hospital","layoffs":null,"summary":"The IWK Hospital in Halifax is offering a new spinal surgery called the ApiFix procedure, which has the potential to dramatically change the way children with scoliosis are treated. The surgery involves using a flexible device developed in Israel that attaches to the spine with screws, allowing for continued flexibility. The surgery is less invasive and takes less time than traditional fusion therapy. The results of the surgery have been positive so far, with patients experiencing improved quality of life and increased participation in physical activities. The surgery has not yet been approved in the United States, but surgeons across North America are closely watching the results.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["spinal surgery","scoliosis","ApiFix procedure","orthopedic surgery","patient testimonials"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"2IY5fiOh7VnvM040R6G7a4VbKLSMVKiSbEFO1keIvQ7vqvE8UigyTv","news_summary":"Ontario teen has 'no more pain' after new scoliosis surgery, but Halifax surgeon urges caution  CBC News","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"300b2904-4a22-40e0-ac62-e3cbeca48448","date":"Jan 2, 2018","link":"http://www.orthospinenews.com/2018/01/02/apifix-ltd-announces-new-leadership/","source":"www.orthospinenews.com","visible":1,"analysis":{"tags":"appointment","company":"ApiFix Ltd.","layoffs":null,"summary":"ApiFix Ltd., a portfolio company of The Trendlines Group Ltd., announced the appointment of Ed Roschak as Chairman of the Board and Paul Mraz as President and CEO. ApiFix provides minimally invasive non-fusion solutions for the treatment of spinal scoliosis. Roschak previously served as President and CEO of Ellipse Technologies, which was acquired by NuVasive for $410 million. Mraz brings 25+ years of spine and orthopedic medical device experience. The appointment is expected to help ApiFix expand in the U.S. and European markets as it finalizes its application for FDA clearance.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["ApiFix","Ed Roschak","Paul Mraz","spinal scoliosis","non-fusion solutions"],"date_of_event":"2 January 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"oGDAnPhLNt3KJLnVTRUGfv9aW1zU1m1AUZ0JEX2iWbTzy4avJQvcPH","news_summary":"ApiFix Ltd. Announces New Leadership - Ortho Spine News","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"77e800f3-fc70-44c4-9f30-10f1793cb575","date":"Sep 5, 2017","link":"https://www.prnewswire.com/news-releases/apifix-signs-distribution-agreement-in-canada-completes-first-cases-in-north-america-at-iwk-health-centre-hospital-halifax-300513439.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"medical device","company":"ApiFix Ltd.","layoffs":null,"summary":"Medical device company ApiFix Ltd. has signed an exclusive distribution agreement in Canada with Joint Solutions Alliance Corp (JSA), a national Canadian medical device and services distribution organization. The agreement allows ApiFix to penetrate the North American market and deliver their non-fusion spinal implant system for the correction of Adolescent Idiopathic Scoliosis (AIS) to more patients around the world. The ApiFix system aims to improve the quality of life for scoliosis patients and reduce costs and recovery time associated with standard scoliosis surgery. The company has CE clearance and is already marketed in several countries.","partners":["Joint Solutions Alliance Corp (JSA)"],"customers":null,"investors":null,"confidence":8,"key_topics":["ApiFix","medical device","distribution agreement","spinal implant system","scoliosis surgery"],"date_of_event":"September 5, 2017","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Xu3GURDS4sFg55pDpjgOllfmJQZBnxhI6NophFPi1t6Y1x1AuxzunF","news_summary":"ApiFix Signs Distribution Agreement in Canada;Completes First Cases in North America at IWK Health Centre Hospital, Halifax","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"11ea46be-e8c5-49b2-8fc4-eef8bd739d43","date":"Aug 8, 2017","link":"http://www.orthospinenews.com/2017/08/08/the-apifix-spinal-implant-receives-tga-certification/","source":"www.orthospinenews.com","visible":1,"analysis":{"tags":"medical device","company":"ApiFix","layoffs":null,"summary":"ApiFix, a portfolio company of The Trendlines Group, has received TGA certification through its distributor Orthotech Pty. Ltd. to begin marketing the ApiFix system in Australia for the treatment and correction of Adolescent Idiopathic Scoliosis (AIS) using an innovative, minimally invasive surgical approach. The certification allows ApiFix to expand its reach and provide treatment for AIS patients in Australia. The ApiFix system is a breakthrough treatment for AIS, offering a minimally invasive, non-fusion spinal implant system that improves the quality of life for patients and is more cost-effective than current scoliosis surgery. Orthotech is committed to innovative orthopedic solutions and is proud to include ApiFix in its suite of products.","partners":"Orthotech Pty. Ltd.","customers":null,"investors":null,"confidence":9,"key_topics":["ApiFix system","Adolescent Idiopathic Scoliosis","minimally invasive surgical approach","TGA certification","Orthotech Pty. Ltd."],"date_of_event":"August 8, 2017","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"KfB0croKRbKVyzfEfcvrjl1D6RCXNKIoTpIMQuHuTB7oubNQVb2F76","news_summary":"The ApiFix Spinal Implant Receives TGA Certification - Ortho Spine News","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"a7777580-fc29-4a2a-b465-4dfe6c34b2cb","date":"Jul 18, 2017","link":"http://www.prnewswire.com/news-releases/apifix-closes-spanish-distribution-deal-with-acuna-fombona-300489865.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"distribution deal","company":"ApiFix","layoffs":null,"summary":"Medical device company ApiFix has signed an exclusive distribution deal in Spain with Acuna-Fombona, a distributor of Spain and Portugal. ApiFix has developed a minimally invasive, non-fusion spinal implant system for the correction of Adolescent Idiopathic Scoliosis (AIS). The distribution deal will help ApiFix expand its presence in Europe and offer its products to Spanish AIS patients. The deal is seen as a growth-positive move for the company.","partners":"Acuna-Fombona","customers":null,"investors":null,"confidence":9,"key_topics":["ApiFix","exclusive distribution deal","minimally invasive spinal implant system","scoliosis correction surgery","expansion in Europe"],"date_of_event":"July 18, 2017","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"e1R2w0mMa7gQ5sYaW8ZsIey0R8IL3BHMYQdyywvo3GVMQOBoG88t2x","news_summary":"ApiFix Closes Spanish Distribution Deal with Acuna-Fombona","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"0eef3f59-3ec4-4812-b47a-f30edb505290","date":"Jan 7, 2017","link":"https://www.israel21c.org/scoliosis-correction-for-kids-just-got-much-less-invasive/","source":"www.israel21c.org","visible":1,"analysis":{"tags":"medical technology","company":"ApiFix","layoffs":null,"summary":"ApiFix, an Israeli company, has developed an internal brace for adolescent scoliosis. The device has been used on 110 patients in Israel and eight European countries and is close to receiving approval from the US FDA. ApiFix is completing a $5 million investment round led by B. Braun. The device, which requires only two screws and a one-hour minimally invasive procedure, allows patients to maintain flexibility in their spine. The company plans to market the device in additional countries and hopes to become the standard treatment for up to 60% of adolescent scoliosis patients. ApiFix will file for FDA approval early this year and expects approval within a year.","partners":null,"customers":null,"investors":"B. Braun","confidence":9,"key_topics":["ApiFix device","scoliosis surgery","FDA approval","spinal medical technology","investment round"],"date_of_event":"2016","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$5 million","structured_issues":["Customers","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"UrCeWOfUeOvWXFbXMVyyNIo0uPeRyBiZdqZaD6uTQYS41caNKlDdQc","news_summary":"Scoliosis correction for kids just got much less invasive","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"6fd44dfe-a085-4937-b569-fd8d4b0a6060","date":"Nov 28, 2016","link":"http://www.globes.co.il/en/article-israeli-spinal-implant-co-apifix-raises-5m-1001163574","source":"www.globes.co.il","visible":1,"analysis":{"tags":"spinal implant, scoliosis, investment","company":"ApiFix","layoffs":null,"summary":"Israeli spinal implant company ApiFix has raised a $5 million Series B investment round. B. Braun Melsungen Aesculap division has invested $2.8 million in the latest financing round. ApiFix is disrupting the scoliosis device market with its minimally invasive, non-fusion spinal implant system. The global market for ApiFix is over $1.15 billion. ApiFix received CE Mark approval in 2012 and is marketing its device in Europe. The funding round will support ApiFixs FDA submission and expansion of clinical and commercial activities in Europe. B. Brauns investment positions ApiFix for accelerated growth and brings their substantial experience to ApiFixs board of directors. B. Braun and Trendlines have a partnership for co-investment and collaboration in the development of new technologies and products.","partners":"B. Braun","customers":null,"investors":"B. Braun Melsungen Aesculap division","confidence":9,"key_topics":["ApiFix","spinal implant","scoliosis","investment","B. Braun"],"date_of_event":"November 28, 2016","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$5 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ZbOIqAm8egQtbjwhSRf8B3he8nov8ukyQO685nslkb85TBuLBp96ie","news_summary":"Israeli spinal implant co ApiFix raises $5m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"01d8a18e-1108-4d8f-a977-294ddcc8f35d","date":"Sep 27, 2016","link":"https://spinalnewsinternational.com/apifix-system-reaches-100-patient-milestone/","source":"spinalnewsinternational.com","visible":1,"analysis":{"tags":"medical technology","company":"ApiFix","layoffs":null,"summary":"The ApiFix system has been used to correct scoliosis in 100 patients, with excellent results. ApiFix has opened new clinical centers in Europe and expects to double the number of cases by the end of 2017.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["ApiFix system","scoliosis correction","minimally invasive procedure","clinical experience","expansion"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"cYTkkexecSrR88AZhMYwG3x1w5fjsi72ai6SG0v2CMEmiVP1LsoyG3","news_summary":"ApiFix system reaches 100-patient milestone - Spinal News International","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"6eecba16-cbd2-476f-b932-f50a9380cc7b","date":"Jul 27, 2015","link":"http://www.haaretz.com/israel-news/business/1.668042","source":"www.haaretz.com","visible":1,"analysis":{"tags":["medical device","scoliosis","spine correction"],"company":"ApiFix","layoffs":null,"summary":"Israeli startup ApiFix has developed a ratcheting device for the treatment of scoliosis. Unlike traditional surgery, the ApiFix device retains the spines flexibility and involves a minimally invasive procedure. The device is suitable for non-severe scoliosis cases and gradually corrects the curvature of the spine through specific spinal exercises. ApiFix has received European CE mark approval and is used in several European countries. It has also received approval from the Israeli Health Ministry and is in the process of obtaining FDA approval in the United States.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["scoliosis","spine correction","ApiFix device","minimally invasive surgery","ratcheting mechanism"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"tOmuDNCgomu5vTLXlUO1gYgDKXDqpEuAoFVnBBGJQ0IizI2vnubTe5","news_summary":"Startup invents ratchet to correct adolescent scoliosis","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7c2be4a0-e967-49e7-9166-94f15f27d766","date":"Feb 15, 2013","link":"https://www.medgadget.com/2013/02/apifix-scoliosis-correction-system-gets-eu-ce-mark.html","source":"www.medgadget.com","visible":1,"analysis":{"tags":"spinal correction implant","company":"ApiFix","layoffs":null,"summary":"ApiFix, a company based in Misgav, Israel, has received European regulatory approval to market its ratcheting spinal correction implant. The implant is designed for adolescent idiopathic scoliosis and consists of a ratchet that spans between two screws implanted into the spine. ApiFix successfully completed a pilot clinical trial in Europe, demonstrating the implants safety and success in correcting the curvature. The company achieved impressive results within about three months. With the CE Mark, ApiFix can now commercially distribute its innovative treatment system for scoliosis.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["European regulatory approval","ratcheting spinal correction implant","adolescent idiopathic scoliosis","pilot clinical trial","CE Mark"],"date_of_event":"February 15th, 2013","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"rKfyq6HWID2ThISztvLIe7q2LVqURWuW7L7al9X2C6ZwqVDlS80Lx5","news_summary":"ApiFix Scoliosis Correction Ratchet Gets EU CE Mark (w/video)","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":17,"techcommunityinvolvement":null,"mediagallery":[{"id":"1034a034-d45c-4347-9dd6-7a1798c51d34","timestamp":"2014-07-27 10:40:30.000000","resources_type":2,"resources_title":"","resources_file_name":"RWoLcYnfq94","alt":"","imageurl":"https://img.youtube.com/vi/RWoLcYnfq94/0.jpg","url":"http://youtu.be/RWoLcYnfq94"}],"tags":["minimally-invasive","surgery","medical-devices","surgeons","orthopedics","healthcare-providers","clinics","hospitals","pediatrics","medical-products"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":[],"geomarkets":["Canada","Europe"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":2,"lastfunding":"$5M","totalrounds":3,"fundingstage":"Acquired","totalfunding":"$8M","publicinvestors":2,"lastpublicfunding":5000000,"totalpublicrounds":3,"totalpublicfunding":8000000},"team":[{"name":"Yizhar Floman","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPL1hZgLDA","bounced":false,"claimed":0,"founder":1,"urlname":"yizhar-floman-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg8smEhQkM","position":"Founder","last_name":"Floman","claimtoken":"413773696b53da1f4ebd845bc6b9611a8af8dd84a05831b87ff9dbe187de5c63","first_name":"Yizhar","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/yizhar-floman-12313819/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2018-06-18 06:51:32.000000","initials":"YF","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Uri Arnin","email":"uri@apifix.com","phone":"0545501406","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGovJcIDA","bounced":false,"claimed":0,"founder":1,"urlname":"uri-arnin","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAnunj3AsM","position":"Founder & CTO","last_name":"Arnin","claimtoken":"PavV7BWEfn04KEJkiIcQ4aF1Ahf430HxFyn2ngr781i8AvtPbESfQU","first_name":"Uri","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/uri-arnin-845bb040/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2023-02-09 14:37:26.000000","initials":"UA","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Daphna  Zaaroor Regev","email":"daphna@apifix.com","phone":"","gender":"Female","userid":"b8znexrOVuV86SlxKAKS2P7o9PNp3Pc9X6szgpm2C8PHYmInVxgpOq","bounced":false,"claimed":null,"founder":0,"urlname":"daphna-zaaroor-regev","visible":1,"memberid":"KKktVprpXl6G514LNUswWPl93JxA510YYSxvQoaXlofMDGAeAA9UaC","position":"Global Scientific and Clinical Affairs Director","last_name":"Zaaroor Regev","claimtoken":"RQ8VotZykXgzeOeQMk01zOsScFxBJn6LIGY9wyUyYp6XgLr6D3kSn5","first_name":"Daphna ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/daphna-zaaroor-regev-ph-d-898b623a/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2023-02-09 14:43:14.000000","initials":"DZ","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Adi  Toister","email":"adi@apifix.com","phone":"","gender":"Male","userid":"FvEFoOznwCqaNoK9WVQanDTmSRp4bDCndHYGwiueb2MsAyU76HPKdb","bounced":false,"claimed":null,"founder":0,"urlname":"adi-toister","visible":1,"memberid":"3glfd2bUDIfZifxGaJEj18QXrBOdL9zH0YYx3SJL5qcEM612q4Z7hg","position":"General Manager & CFO","last_name":"Toister","claimtoken":"nOQ1LJ6WA2AfWfCAW43EjaLNs6n8MGa9nDuOmnEPWsDjKcBpZDMiLe","first_name":"Adi ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/aditoister/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2023-02-09 14:39:09.000000","initials":"AT","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPi8kYoKDA","fullname":"Ayelet Beazley"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":"2020-04-20T00:00:00.000Z","crunchbaseid":"apifix","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Arielle Smolin","creator_email":"ari.smolin@gmail.com","createdate":"2014-07-17T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":"Ayelet Beazley","affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCOmcuQCAw","date":"Apr 2020","amount":"$67M","source":"https://en.globes.co.il/en/article-orthopediatrics-buys-israeli-co-apifix-for-40m-1001324347","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Orthopediatrics","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOD21YzeCgw","acquiredcompany_mna_type":"Company","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/company_page/orthopediatrics","acquiredcompany_mna_logokey":"$lxrm0RB3JS6jiMn2hT5xPEKbcgQlbBcISKy8YHddh6kLvCBRPP3wtv","acquiredcompany_mna_urlname":"/company_page/orthopediatrics","acquiredcompany_mna_homepage":null,"style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$lxrm0RB3JS6jiMn2hT5xPEKbcgQlbBcISKy8YHddh6kLvCBRPP3wtv","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":67000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEtpPSCgw","date":"Apr 2019","amount":"$5M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"The Trendlines Group","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/the-trendlines-group","logokey":"$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","tagline":null,"urlname":"/investor_page/the-trendlines-group","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7j4IwJDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"38e5ad35-2d9a-4ecb-ad69-2bdc05364e6f","fundingsubtype":"Incubator","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","leadcaption":"","followupcaption":""},{"name":"B. Braun Melsungen AG","type":"Company","amount":0,"hidden":true,"country":"Germany","fullurl":"/company_page/b-braun-melsungen-ag","logokey":"$E3jfpr9nFLqGq9Mh0dTUU5VN0tNqNAzn2UjXG7HvhS0hmMgO1Aw2LP","tagline":"","urlname":"/company_page/b-braun-melsungen-ag","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEjZO7Cgw","fundingtype":"Company","leadpartner":null,"investmentid":"3ffedf1a-d666-4f64-97e7-e2d13abd426a","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$E3jfpr9nFLqGq9Mh0dTUU5VN0tNqNAzn2UjXG7HvhS0hmMgO1Aw2LP","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkmsfpCww","date":"Mar 2013","amount":"$3M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEu6DpCAw","date":"Mar 2011","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"3/2011","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"ApiFix","logourl":"https://storage.googleapis.com/clean-finder-353810/$Faxzl9aC8tgpMBgK4CxF2hGkEu1caA185Xaq6Ja84UBkd99jZR6ZHF","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$Faxzl9aC8tgpMBgK4CxF2hGkEu1caA185Xaq6Ja84UBkd99jZR6ZHF","seoabout":"ApiFix provides a minimally invasive scoliosis correction system for treating patients with adolescent idiopathic scoliosis whoare classified as Lenke type...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":4,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"},{"title":"Patients","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"}]}]}],"coreTechnology":[]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":[],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers","Patients"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCOmcuQCAw","date":"Apr 2020","amount":"$67M","source":"https://en.globes.co.il/en/article-orthopediatrics-buys-israeli-co-apifix-for-40m-1001324347","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Orthopediatrics","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOD21YzeCgw","acquiredcompany_mna_type":"Company","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/company_page/orthopediatrics","acquiredcompany_mna_logokey":"$lxrm0RB3JS6jiMn2hT5xPEKbcgQlbBcISKy8YHddh6kLvCBRPP3wtv","acquiredcompany_mna_urlname":"/company_page/orthopediatrics","acquiredcompany_mna_homepage":null,"style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$lxrm0RB3JS6jiMn2hT5xPEKbcgQlbBcISKy8YHddh6kLvCBRPP3wtv","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":67000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEtpPSCgw","date":"Apr 2019","amount":"$5M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"The Trendlines Group","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/the-trendlines-group","logokey":"$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","tagline":null,"urlname":"/investor_page/the-trendlines-group","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7j4IwJDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"38e5ad35-2d9a-4ecb-ad69-2bdc05364e6f","fundingsubtype":"Incubator","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","leadcaption":"","followupcaption":""},{"name":"B. Braun Melsungen AG","type":"Company","amount":0,"hidden":true,"country":"Germany","fullurl":"/company_page/b-braun-melsungen-ag","logokey":"$E3jfpr9nFLqGq9Mh0dTUU5VN0tNqNAzn2UjXG7HvhS0hmMgO1Aw2LP","tagline":"","urlname":"/company_page/b-braun-melsungen-ag","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEjZO7Cgw","fundingtype":"Company","leadpartner":null,"investmentid":"3ffedf1a-d666-4f64-97e7-e2d13abd426a","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$E3jfpr9nFLqGq9Mh0dTUU5VN0tNqNAzn2UjXG7HvhS0hmMgO1Aw2LP","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkmsfpCww","date":"Mar 2013","amount":"$3M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEu6DpCAw","date":"Mar 2011","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}